Healthcare Cold Chain Logistics Market Scope
Cold chain logistics in healthcare refers to a temperature-controlled supply chain that is required to maintain the shelf life and quality and of the pharmaceutical products. The healthcare cold chain logistics market is gaining a rapid momentum from manufacturing to supply of the pharmaceutical products. Market players are focusing on technological advancement in the cold chain market. For instance, FedEx launched Senseware to meet the rising logistics demands of the healthcare sector in the Philippines. Moreover, owing to increasing demand for generic and temperature-sensitive medicines, cold chain logistics market expected to retain its lead throughout the forecast period. Moreover,
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Kuehne and Nagel International AG (Switzerland), DB Schenker Inc. (Germany), United Parcel Service Inc. (United States), DHL International GmbH (Germany), FedEx Corporation (United States), AmerisourceBergen Corporation (United States), Marken (United States), American Airlines, Inc. (United States) and Cavalier Logistics (United States) |
CAGR | % |
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Healthcare Cold Chain Logistics market throughout the predicted period.
Kuehne and Nagel International AG (Switzerland), DB Schenker Inc. (Germany), United Parcel Service Inc. (United States), DHL International GmbH (Germany), FedEx Corporation (United States), AmerisourceBergen Corporation (United States), Marken (United States), American Airlines, Inc. (United States) and Cavalier Logistics (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Kool-ex cold chain (India), Sensitech (United States), Zest Labs (United States) and KUEHNE + NAGEL (Switzerland).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Healthcare Cold Chain Logistics market by Type and Region with country level break-up.
On the basis of geography, the market of Healthcare Cold Chain Logistics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
“According to the Food and Drug Administration (FDA), the cold chain is a system of storing and transporting vaccines at recommended temperatures from the point of manufacture to the point of use. The equipment included in the cold chain is expected to provide 'EPI standard' vaccine storage. The capacity needs to provide for transport and storage of all vaccines required for routine immunization of all children under 1 year of age (4%) and all women of childbearing age, groups that constitute 4% and 23% of the total population in Ethiopia, respectively. The cold chain is also expected to provide for the needs related to various supplementary immunization activities at any given time.”
Influencing Trend:
Rising Demand for Temperature Sensitive Medicines and Technological Advancement in the Healthcare Industry
Market Growth Drivers:
Rising Demand for Technologically Advanced Systems for Distribution of Drugs and Increasing Number of Clinical Trials
Challenges:
Lack of Suitable Infratstrure in the Emerging Economies
Restraints:
Stringent Government Regulations Regarding Healthcare Cold Chain Logistics and Complex Installation Process and High Cost of Cold Chain Logistics
Opportunities:
Increasing Demand for the Generic Drugs and Growing Healthcare Infratstrure in the Developing Economies
Key Target Audience
Healthcare Cold Chain Logistics Service Providers, Warehousing Service Providers, Cold Chain Equipment Manufacturers and Suppliers, Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Venture Capitalists and Investors and Others